红灯闪笔和儿童发作
Simone Gasparini1, Alice Dainelli1, Francesca Piras1
1Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS, Florence, Italy.
Developmental medicine and child neurology
|October 3, 2025
概括
两名年轻女孩经历了因闪的红灯引发的缺席发作. 这凸显了不受监管的消费品带来的风险,以及为儿童更新安全标准的必要性.
科学领域:
- 神经学 神经学
- 儿科 儿科 儿科
- 生物医学工程 生物医学工程
背景情况:
- 光敏感性是最常见的刺激诱导性的形式.
- 消费品中的闪灯带来风险,特别是对儿童来说.
- 目前的法规不充分解决新兴的LED技术.
研究的目的:
- 描述了两个儿童长期出现光学诱导的缺席发作的病例.
- 为了调查商业闪灯产品的诱发的潜力.
- 强调需要更新发光技术的安全标准.
主要方法:
- 进行了临床评估和带有间歇性光刺激的脑电图 (EEG).
- 研究了两个不相关的9岁和10岁的女性患者.
- 脑电图显示了普遍的光发反应反应.
主要成果:
- 两位患者都经历了由商业红灯闪笔引发的缺席发作.
- 脑电图显示了对间歇性光刺激的普遍光囊性反应.
- 这位9岁的患者在接触到笔时表现出强烈的光性排泄.
结论:
- 瓦尔酸,预防措施和触发器避免成功治疗了这两名患者.
- 消费者产品的闪灯调节不良,存在重大风险.
- 更新的安全标准对于保护弱势群体免受引起的刺激至关重要.
相关概念视频
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Seizures: Classification
1.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
822
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
822


